Concentrations of hepatocyte growth factor, basic fibroblast growth factor, and vascular endothelial growth factor in pericardial fluid and plasma.

Some angiogenic factors, including hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF), and vascular endothelial growth factor (VEGF), have been reported to promote angiogenesis and improve myocardial perfusion in experimental models of ischemic heart disease. These factors are produced in various tissues, including myocardium. We measured the concentrations of HGF, bFGF, and VEGF by enzyme-linked immunosorbent assay in plasma and in pericardial fluid sampled during open heart surgery (12 patients with ischemic heart disease and 17 with nonischemic heart disease). HGF levels were significantly higher in plasma than in pericardial fluid (12.0 +/- 1.8 versus 0.26 +/- 0.04 ng/mL, P < 0.0001). On the other hand, bFGF levels were significantly higher in pericardial fluid than in plasma (243.5 +/- 50.9 versus 49.6 +/- 7.8 pg/mL, P = 0.009). VEGF levels were not significantly different between pericardial fluid and plasma (47.2 +/- 17.6 versus 24.5 +/- 3.6 pg/mL, P = 0.23). Concentrations of angiogenic factors in pericardial fluid and in plasma were not significantly different between patients with ischemic and nonischemic heart disease. These results suggest that the production, secretion, and kinetics of HGF, bFGF, and VEGF are different. These angiogenic factors may have different pathophysiologic roles.

[1]  J. Montani,et al.  Growth regulation of the vascular system: evidence for a metabolic hypothesis. , 1990, The American journal of physiology.

[2]  J. Folkman,et al.  Isolation, characterization, and localization of heparin-binding growth factors in the heart. , 1990, The Journal of clinical investigation.

[3]  S. Yasuda,et al.  Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function. , 2000, Journal of the American College of Cardiology.

[4]  M. Aoyagi,et al.  Localization and effects of hepatocyte growth factor on smooth muscle cells during neointimal formation after balloon denudation , 1999, Histochemistry and Cell Biology.

[5]  D. Gospodarowicz,et al.  Structural characterization and biological functions of fibroblast growth factor. , 1987, Endocrine reviews.

[6]  Y. Kihara,et al.  Marked elevation of vascular endothelial growth factor and basic fibroblast growth factor in pericardial fluid of patients with angina pectoris , 2004, Angiogenesis.

[7]  R. Ogilvie,et al.  Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. , 1996, Circulation research.

[8]  Y. Taniyama,et al.  Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. , 1999, Hypertension.

[9]  K. Matsumoto,et al.  Emerging multipotent aspects of hepatocyte growth factor. , 1996, Journal of biochemistry.

[10]  R. Nohara,et al.  Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. , 1996, Circulation.

[11]  A. Mebazaa,et al.  Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. , 1997, Circulation research.

[12]  M. Aoki,et al.  Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF system. , 1997, Journal of atherosclerosis and thrombosis.

[13]  Y. Uchida,et al.  Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. , 1992, Science.

[14]  Y. Kihara,et al.  Pericardial fluid from patients with ischemic heart disease accelerates the growth of human vascular smooth muscle cells. , 2000, Japanese circulation journal.

[15]  Y. Taniyama,et al.  Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets , 2000, Gene Therapy.

[16]  S. Epstein,et al.  Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. , 1996, Circulation.

[17]  J. Isner,et al.  Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.

[18]  A. Quyyumi,et al.  Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. , 2000, Journal of the American College of Cardiology.

[19]  K. Matsumoto,et al.  Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats. , 1997, Hypertension.

[20]  U. Ikeda,et al.  Expression of vascular endothelial growth factor in patients with acute myocardial infarction. , 2000, Journal of the American College of Cardiology.

[21]  Y. Uchida,et al.  Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: an experimental study. , 1995, American heart journal.

[22]  V. Dilsizian,et al.  Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease , 2000, Circulation.

[23]  N. Ferrara,et al.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[24]  N. Mochizuki,et al.  Expression of vascular endothelial growth factor in human myocardial infarction , 2005, Heart and Vessels.

[25]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[26]  K Walsh,et al.  Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.

[27]  J. Isner,et al.  Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. , 1996, Circulation.

[28]  A. Matsumori,et al.  Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. , 1996, Biochemical and biophysical research communications.

[29]  C. Ibukiyama,et al.  Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction. , 1999, Japanese circulation journal.